Search Results 1-10 of 13760 for Tyrosine

1. Nitisinone (oral route) - Side effects & dosage - Mayo Clinic

   Description. Nitisinone is used to treat hereditary tyrosinemia type 1, which is too much tyrosine in the blood. It helps to prevent high levels of tyrosine ...

2. [18F] Fluoroethyl-L-tyrosine PET/MRI for identifying small functional pituitary adenomas - Mayo Clinic

   [18F] Fluoroethyl-L-tyrosine PET/MRI for identifying small functional pituitary adenomas · Overview · Participation eligibility · Participating Mayo Clinic ...

3. MAOIs and diet: Is it necessary to restrict tyramine? - Mayo Clinic

   It's found naturally in the body. It's also found in certain foods. Medicines used to treat depression called monoamine oxidase inhibitors (MAOIs) can affect ...

4. Testing The Use Of Steroids And Tyrosine Kinase Inhibitors With Blinatumomab Or Chemotherapy For Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia In Adults - Mayo Clinic

   About this study. This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same ...

5. Pharmacogenomic Testing in Patients with Hand-Foot Skin Reaction on Tyrosine Kinase Inhibitors - Mayo Clinic

   Pharmacogenomic Testing in Patients with Hand-Foot Skin Reaction on Tyrosine Kinase Inhibitors · Overview · Participation eligibility · Participating Mayo Clinic ...

6. A Study Of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) In Participants With Chronic Lymphocytic Leukemia (CLL) And Other B-cell Malignancies - Mayo Clinic

   A Study Of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) In Participants With Chronic Lymphocytic Leukemia (CLL) And Other B-cell ...

7. A Study of Tyrosine Kinase Inhibitor ICP-022 in Patients With r/r B-Cell Malignancies - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

   A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With ...

9. Chemical Biology of Microbes and Membrane Proteins: Nate Traaseth - Mayo Clinic Research

   Cellular signaling mediated by receptor tyrosine kinases. Receptor tyrosine kinase genes in humans regulate essential biological processes, including ...

10. Isotope ratio measurements - Metabolomics Core - Mayo Clinic Research

    H4]tyrosine, [¹³C]ketoisocaproic acid, [¹⁵N]tyrosine, [1-¹³C]leucine. [¹⁵N]glutamate, [¹⁵N]glutamine, [¹⁵N]ornithine, [¹⁵N]aspartate. [¹⁵N]arginine, [¹⁵N] ...